当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:1287.47亿  总市值:1486.74亿
流通股本:25.01亿   总股本:28.88亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润66.02亿元,每股收益2.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益5558324.21万元,未分配利润2942436.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产7423823.99万元,负债1865499.78万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入27,702,002,254.7617,240,918,263.027,981,934,236.9640,340,806,877.04
营业总成本19,967,164,047.6212,203,655,162.935,643,908,863.6428,708,590,806.38
营业利润7,890,869,263.365,078,454,076.272,309,847,178.7611,872,285,906.47
利润总额7,854,296,089.215,049,553,770.352,297,394,139.811,831,990,991.15
净利润6,601,611,515.974,280,845,682.911,958,853,204.959,700,260,033.27
其他综合收益-3,353,834.7614,733,694.61-213,721,368.5286,920,855.5
综合收益总额6,598,257,681.214,295,579,377.521,745,131,836.439,787,180,888.77
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计30,462,748,877.1230,261,138,249.1131,153,381,549.1930,422,470,960.82
非流动资产合计43,775,490,998.1144,136,190,407.7843,786,466,187.3843,246,878,346.3
资产总计74,238,239,875.2374,397,328,656.8974,939,847,736.5773,669,349,307.12
流动负债合计12,927,421,099.0213,648,375,448.3113,387,432,882.5414,756,296,165.57
非流动负债合计5,727,576,674.225,654,192,029.35,504,117,842.473,395,607,728.81
负债合计18,654,997,773.2419,302,567,477.6118,891,550,725.0118,151,903,894.38
归属于母公司股东权益合计55,173,547,660.3854,713,936,892.4755,639,487,743.3455,122,453,910.73
股东权益合计55,583,242,101.9955,094,761,179.2856,048,297,011.5655,517,445,412.74
负债和股东权益合计74,238,239,875.2374,397,328,656.8974,939,847,736.5773,669,349,307.12
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计31,246,847,172.8320,572,914,715.2910,421,436,141.2342,272,825,974.7
经营活动现金流出小计22,867,754,787.6815,606,620,527.928,164,318,333.3728,885,914,195.93
经营活动产生的现金流量净额8,379,092,385.154,966,294,187.372,257,117,807.8613,386,911,778.77
投资活动现金流入小计5,519,181,400.723,331,857,536.152,189,367,1362,899,446,215.91
投资活动现金流出小计8,713,398,273.855,306,598,872.733,043,749,990.6210,459,979,779.62
投资活动产生的现金流量净额-3,194,216,873.13-1,974,741,336.58-854,382,854.62-7,560,533,563.71
筹资活动现金流入小计8,282,155,280.665,575,838,145.112,929,323,063.977,090,611,257.54
筹资活动现金流出小计14,187,039,758.569,037,526,297.462,972,618,043.2111,031,994,942.27
筹资活动产生的现金流量净额-5,904,884,477.9-3,461,688,152.35-43,294,979.24-3,941,383,684.73
汇率变动对现金及现金等价物的影响-9,427,113.53168,611,655.79156,482,470.23132,139,998.6
现金及现金等价物净增加额-729,436,079.41-301,523,645.771,515,922,444.232,017,134,528.93
期末现金及现金等价物余额9,271,602,732.619,699,515,166.2511,516,961,256.2510,001,038,812.02
最新报告期:2024-11-26
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信证券陈竹3.333.794.382024-11-26
中信建投刘若飞,贺菊颖3.253.694.142024-11-07
长城证券于夕朦3.253.754.302024-11-07
财通证券张文录3.213.654.092024-11-04
国信证券张佳博,彭思宇3.183.634.142024-11-03
TOP↑